Sunday September 27, 2020

Life and death: At mercy of the market

There are more rational ways to decide who gets resources, and who does not

5th June, 2016

Imagine a new drug has been invented that would save only one person, but which would take the entire health budget to administer it to them. Should you sanction the use of the drug? The pot of money is finite. All other resources will be diverted and stopped. Others will suffer, if not die, because of your decision. If you don’t give that person the new drug, they will die.

What would you...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader



Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.



€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.




90 Day Pass

You can cancel any time.

2 Yearly



Unlimited Access for 2 Years

This product does not auto-renew

Team Pass

Get a Business Account for you and your team

Related Stories

Demand continues to outstrip supply in both residential and PRS markets, while developers adapt new build designs to take the pandemic into account

Tina-Marie O'Neill | 3 weeks ago

Several strategic changes offer an opportunity for positive reform of planning and development

Niall Byrne | 3 weeks ago

The United States cannot defeat the pandemic like a military foe but it can learn from looking back at its post-war economic recovery

Todd G Buchholz | 1 month ago